Markers to measure immunomodulation in human nutrition intervention studies - PubMed (original) (raw)
Review
Markers to measure immunomodulation in human nutrition intervention studies
Ruud Albers et al. Br J Nutr. 2005 Sep.
Abstract
Normal functioning of the immune system is crucial to the health of man, and diet is one of the major exogenous factors modulating individual immunocompetence. Recently, nutrition research has focused on the role of foods or specific food components in enhancing immune system responsiveness to challenges and thereby improving health and reducing disease risks. Assessing diet-induced changes of immune function, however, requires a thorough methodological approach targeting a large spectrum of immune system parameters. Currently, no single marker is available to predict the outcome of a dietary intervention on the resistance to infection or to other immune system-related diseases. The present review summarises the immune function assays commonly used as markers in human intervention studies and evaluates their biological relevance (e.g. known correlation with clinically relevant endpoints), sensitivity (e.g. within- and between-subject variation), and practical feasibility. Based on these criteria markers were classified into three categories with high, medium or low suitability. Vaccine-specific serum antibody production, delayed-type hypersensitivity response, vaccine-specific or total secretory IgA in saliva and the response to attenuated pathogens, were classified as markers with high suitability. Markers with medium suitability include natural killer cell cytotoxicity, oxidative burst of phagocytes, lymphocyte proliferation and the cytokine pattern produced by activated immune cells. Since no single marker allows conclusions to be drawn about the modulation of the whole immune system, except for the clinical outcome of infection itself, combining markers with high and medium suitability is currently the best approach to measure immunomodulation in human nutrition intervention studies. It would be valuable to include several immune markers in addition to clinical outcome in future clinical trials in this area, as there is too little evidence that correlates markers with global health improvement.
Similar articles
- Assessing immune function changes in exercise and diet intervention studies.
Gleeson M. Gleeson M. Curr Opin Clin Nutr Metab Care. 2005 Sep;8(5):511-5. doi: 10.1097/01.mco.0000170760.63490.95. Curr Opin Clin Nutr Metab Care. 2005. PMID: 16079621 Review. - Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health.
Albers R, Bourdet-Sicard R, Braun D, Calder PC, Herz U, Lambert C, Lenoir-Wijnkoop I, Méheust A, Ouwehand A, Phothirath P, Sako T, Salminen S, Siemensma A, van Loveren H, Sack U. Albers R, et al. Br J Nutr. 2013 Aug;110 Suppl 2:S1-30. doi: 10.1017/S0007114513001505. Br J Nutr. 2013. PMID: 23902657 - Use of T cell function to determine the effect of physiologically active food components.
Field CJ. Field CJ. Am J Clin Nutr. 2000 Jun;71(6 Suppl):1720S-5S; discussion 1726S-7S. doi: 10.1093/ajcn/71.6.1720S. Am J Clin Nutr. 2000. PMID: 10837328 Review. - Is regular exercise a friend or foe of the aging immune system? A systematic review.
Haaland DA, Sabljic TF, Baribeau DA, Mukovozov IM, Hart LE. Haaland DA, et al. Clin J Sport Med. 2008 Nov;18(6):539-48. doi: 10.1097/JSM.0b013e3181865eec. Clin J Sport Med. 2008. PMID: 19001887 Review. - Exercise, nutrition and immune function.
Gleeson M, Nieman DC, Pedersen BK. Gleeson M, et al. J Sports Sci. 2004 Jan;22(1):115-25. doi: 10.1080/0264041031000140590. J Sports Sci. 2004. PMID: 14971437 Review.
Cited by
- Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability.
Gleize B, Tourniaire F, Depezay L, Bott R, Nowicki M, Albino L, Lairon D, Kesse-Guyot E, Galan P, Hercberg S, Borel P. Gleize B, et al. Br J Nutr. 2013 Jul 14;110(1):1-10. doi: 10.1017/S0007114512004813. Epub 2012 Dec 11. Br J Nutr. 2013. PMID: 23228631 Free PMC article. - Combination of the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis, BB-12 Has Limited Effect on Biomarkers of Immunity and Inflammation in Older People Resident in Care Homes: Results From the Probiotics to Reduce Infections iN CarE home reSidentS Randomized, Controlled Trial.
Castro-Herrera VM, Fisk HL, Wootton M, Lown M, Owen-Jones E, Lau M, Lowe R, Hood K, Gillespie D, Hobbs FDR, Little P, Butler CC, Miles EA, Calder PC. Castro-Herrera VM, et al. Front Immunol. 2021 Mar 4;12:643321. doi: 10.3389/fimmu.2021.643321. eCollection 2021. Front Immunol. 2021. PMID: 33746986 Free PMC article. Clinical Trial. - Immunosupportive therapies in aging.
Fülöp T, Larbi A, Hirokawa K, Mocchegiani E, Lesourds B, Castle S, Wikby A, Franceschi C, Pawelec G. Fülöp T, et al. Clin Interv Aging. 2007;2(1):33-54. doi: 10.2147/ciia.2007.2.1.33. Clin Interv Aging. 2007. PMID: 18044074 Free PMC article. Review. - The nutrition and immunity (nutrIMM) study: protocol for a non-randomized, four-arm parallel-group, controlled feeding trial investigating immune function in obesity and type 2 diabetes.
Braga Tibaes JR, Barreto Silva MI, Makarowski A, Cervantes PB, Richard C. Braga Tibaes JR, et al. Front Nutr. 2023 Sep 1;10:1243359. doi: 10.3389/fnut.2023.1243359. eCollection 2023. Front Nutr. 2023. PMID: 37727636 Free PMC article. - Age-Related Changes in the Natural Killer Cell Response to Seasonal Influenza Vaccination Are Not Influenced by a Synbiotic: a Randomised Controlled Trial.
Przemska-Kosicka A, Childs CE, Maidens C, Dong H, Todd S, Gosney MA, Tuohy KM, Yaqoob P. Przemska-Kosicka A, et al. Front Immunol. 2018 Mar 22;9:591. doi: 10.3389/fimmu.2018.00591. eCollection 2018. Front Immunol. 2018. PMID: 29662493 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous